A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk

NCT05646056 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2024-10-24

No results posted yet for this study

Summary

This is a non-invasive/observational study in healthy and mild HF subjects utilizing clinical and ambulatory measurements to improve detection, monitoring, and management of HF risks.

Conditions

  • Heart Failure
  • Cardiomyopathy, Hypertrophic
  • Left Ventricular Hypertrophy

Interventions

DEVICE

Software

Observation only

Sponsors & Collaborators

  • Prolaio

    lead INDUSTRY

Principal Investigators

  • Michael Koren, MD · Jacksonville Center For Clinical Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-28
Primary Completion
2024-09-18
Completion
2024-09-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05646056 on ClinicalTrials.gov